Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXK2OO
|
||||
| Drug Name |
[2-(Benzofuran-7-yloxy)-ethyl]-[3-(5-fluoro-1H-indol-3-yl)-propyl]-amine
|
||||
| Synonyms |
CHEMBL126407
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C21H21FN2O2
|
||||
| Canonical SMILES |
Fc1ccc2[nH]cc(CCCNCCOc3cccc4ccoc34)c2c1
|
||||
| InChI |
InChI=1S/C21H21FN2O2/c22-17-6-7-19-18(13-17)16(14-24-19)4-2-9-23-10-12-25-20-5-1-3-15-8-11-26-21(15)20/h1,3,5-8,11,13-14,23-24H,2,4,9-10,12H2
|
||||
| InChIKey |
WNRBGXHMJJCVAE-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.